Ms. Suma M. Krishnan's most recent trade in Krystal Biotech Inc was a trade of 3,962 Common Stock done at an average price of $357.6 . Disclosure was reported to the exchange on Sept. 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 357.57 per share. | 04 Sep 2026 | 3,962 | 1,317,390 (7%) | 0% | 357.6 | 1,416,709 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 359.39 per share. | 04 Sep 2026 | 3,392 | 1,310,818 (7%) | 0% | 359.4 | 1,219,038 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 356.37 per share. | 04 Sep 2026 | 3,267 | 1,321,352 (7%) | 0% | 356.4 | 1,164,254 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 358.42 per share. | 04 Sep 2026 | 3,180 | 1,314,210 (7%) | 0% | 358.4 | 1,139,777 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 360.47 per share. | 04 Sep 2026 | 2,320 | 1,308,498 (7%) | 0% | 360.5 | 836,281 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 355.57 per share. | 04 Sep 2026 | 2,006 | 1,324,619 (7%) | 0% | 355.6 | 713,277 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 362.65 per share. | 04 Sep 2026 | 1,992 | 1,305,264 (7%) | 0% | 362.7 | 722,404 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 364.48 per share. | 04 Sep 2026 | 1,329 | 1,303,370 (7%) | 0% | 364.5 | 484,390 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 361.61 per share. | 04 Sep 2026 | 1,242 | 1,307,256 (7%) | 0% | 361.6 | 449,120 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 365.41 per share. | 04 Sep 2026 | 826 | 1,302,544 (7%) | 0% | 365.4 | 301,832 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 363.34 per share. | 04 Sep 2026 | 565 | 1,304,699 (7%) | 0% | 363.3 | 205,287 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 354.54 per share. | 04 Sep 2026 | 520 | 1,326,625 (7%) | 0% | 354.5 | 184,361 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 366.56 per share. | 04 Sep 2026 | 399 | 1,302,145 (7%) | 0% | 366.6 | 146,256 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 307.81 per share. | 04 Jun 2026 | 12,729 | 1,387,038 (8%) | 0% | 307.8 | 3,918,070 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 308.89 per share. | 04 Jun 2026 | 3,803 | 1,383,235 (7%) | 0% | 308.9 | 1,174,708 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 309.95 per share. | 04 Jun 2026 | 2,801 | 1,380,434 (7%) | 0% | 309.9 | 868,156 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 310.94 per share. | 04 Jun 2026 | 2,039 | 1,378,395 (7%) | 0% | 310.9 | 634,001 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 307.09 per share. | 04 Jun 2026 | 1,348 | 1,399,767 (8%) | 0% | 307.1 | 413,964 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 302.25 per share. | 04 Jun 2026 | 593 | 1,402,242 (8%) | 0% | 302.3 | 179,235 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 305.86 per share. | 04 Jun 2026 | 480 | 1,401,115 (8%) | 0% | 305.9 | 146,815 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 304.90 per share. | 04 Jun 2026 | 400 | 1,401,595 (8%) | 0% | 304.9 | 121,958 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 300.75 per share. | 04 Jun 2026 | 320 | 1,402,835 (8%) | 0% | 300.8 | 96,240 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 303.17 per share. | 04 Jun 2026 | 247 | 1,401,995 (8%) | 0% | 303.2 | 74,883 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 311.65 per share. | 04 Jun 2026 | 240 | 1,378,155 (7%) | 0% | 311.7 | 74,796 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 265.16 per share. | 04 Mar 2026 | 6,000 | 1,404,855 (8%) | 0% | 265.2 | 1,590,979 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 265.16 per share. | 04 Mar 2026 | 6,000 | 1,404,855 (8%) | 0% | 265.2 | 1,590,979 | - |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 264.64 per share. | 04 Mar 2026 | 4,852 | 1,410,855 (8%) | 0% | 264.6 | 1,284,019 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 264.64 per share. | 04 Mar 2026 | 4,852 | 1,410,855 (8%) | 0% | 264.6 | 1,284,019 | - |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 260.37 per share. | 04 Mar 2026 | 3,667 | 1,422,824 (8%) | 0% | 260.4 | 954,762 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 260.37 per share. | 04 Mar 2026 | 3,667 | 1,422,824 (8%) | 0% | 260.4 | 954,762 | - |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 261.41 per share. | 04 Mar 2026 | 2,931 | 1,419,893 (8%) | 0% | 261.4 | 766,198 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 261.41 per share. | 04 Mar 2026 | 2,931 | 1,419,893 (8%) | 0% | 261.4 | 766,198 | - |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 263.58 per share. | 04 Mar 2026 | 2,248 | 1,415,707 (8%) | 0% | 263.6 | 592,535 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 263.58 per share. | 04 Mar 2026 | 2,248 | 1,415,707 (8%) | 0% | 263.6 | 592,535 | - |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 262.35 per share. | 04 Mar 2026 | 1,938 | 1,417,955 (8%) | 0% | 262.3 | 508,430 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 262.35 per share. | 04 Mar 2026 | 1,938 | 1,417,955 (8%) | 0% | 262.3 | 508,430 | - |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 266.42 per share. | 04 Mar 2026 | 1,700 | 1,403,155 (8%) | 0% | 266.4 | 452,918 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 266.42 per share. | 04 Mar 2026 | 1,700 | 1,403,155 (8%) | 0% | 266.4 | 452,918 | - |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 259.61 per share. | 04 Mar 2026 | 668 | 1,426,491 (8%) | 0% | 259.6 | 173,419 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 259.61 per share. | 04 Mar 2026 | 668 | 1,426,491 (8%) | 0% | 259.6 | 173,419 | - |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 258.54 per share. | 04 Mar 2026 | 589 | 1,427,159 (8%) | 0% | 258.5 | 152,280 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 258.54 per share. | 04 Mar 2026 | 589 | 1,427,159 (8%) | 0% | 258.5 | 152,280 | - |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 257.32 per share. | 04 Mar 2026 | 407 | 1,427,748 (8%) | 0% | 257.3 | 104,729 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 257.32 per share. | 04 Mar 2026 | 407 | 1,427,748 (8%) | 0% | 257.3 | 104,729 | - |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | 27 Feb 2026 | 43,536 | 43,536 | - | - | Performance Stock Units | ||
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 26,250 | 1,509,075 (8%) | 0% | 0 | Common Stock | |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 26,250 | 1,509,075 (8%) | 0% | 0 | - | |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 22,500 | 1,436,211 (8%) | 0% | 0 | Common Stock | |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | 27 Feb 2026 | 22,500 | 0 | - | - | Performance Stock Units | ||
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 22,500 | 1,436,211 (8%) | 0% | 0 | - | |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | 27 Feb 2026 | 18,100 | 18,100 | - | - | Stock Option (Right to Buy) | ||
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 275.64 per share. | 27 Feb 2026 | 11,942 | 1,497,133 (8%) | 0% | 275.6 | 3,291,693 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 275.64 per share. | 27 Feb 2026 | 11,942 | 1,497,133 (8%) | 0% | 275.6 | 3,291,693 | - |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 275.64 per share. | 27 Feb 2026 | 10,236 | 1,425,975 (8%) | 0% | 275.6 | 2,821,451 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 275.64 per share. | 27 Feb 2026 | 10,236 | 1,425,975 (8%) | 0% | 275.6 | 2,821,451 | - |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 8,750 | 1,486,806 (8%) | 0% | 0 | Common Stock | |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 8,750 | 1,486,806 (8%) | 0% | 0 | - | |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | 27 Feb 2026 | 7,256 | 7,256 | - | - | Restricted Stock Units | ||
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 5,725 | 1,502,858 (8%) | 0% | 0 | Common Stock | |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 5,725 | 1,502,858 (8%) | 0% | 0 | - | |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 4,000 | 1,429,975 (8%) | 0% | 0 | Common Stock | |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | 27 Feb 2026 | 4,000 | 12,000 | - | - | Restricted Stock Units | ||
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 4,000 | 1,429,975 (8%) | 0% | 0 | - | |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 275.64 per share. | 27 Feb 2026 | 3,981 | 1,482,825 (8%) | 0% | 275.6 | 1,097,323 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 275.64 per share. | 27 Feb 2026 | 3,981 | 1,482,825 (8%) | 0% | 275.6 | 1,097,323 | - |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 275.64 per share. | 27 Feb 2026 | 2,605 | 1,500,253 (8%) | 0% | 275.6 | 718,042 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 275.64 per share. | 27 Feb 2026 | 2,605 | 1,500,253 (8%) | 0% | 275.6 | 718,042 | - |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 275.64 per share. | 27 Feb 2026 | 1,820 | 1,428,155 (8%) | 0% | 275.6 | 501,665 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 275.64 per share. | 27 Feb 2026 | 1,820 | 1,428,155 (8%) | 0% | 275.6 | 501,665 | - |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 221.78 per share. | 04 Dec 2025 | 10,505 | 1,483,756 (8%) | 0% | 221.8 | 2,329,772 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 221.82 per share. | 04 Dec 2025 | 10,461 | 1,413,911 (8%) | 0% | 221.8 | 2,320,471 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 219.53 per share. | 04 Dec 2025 | 5,693 | 1,496,886 (8%) | 0% | 219.5 | 1,249,803 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 219.68 per share. | 04 Dec 2025 | 5,419 | 1,426,999 (8%) | 0% | 219.7 | 1,190,423 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Dec 2025 | 5,000 | 1,478,056 (8%) | 0% | 0 | Common Stock | |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 218.83 per share. | 04 Dec 2025 | 3,593 | 1,432,418 (8%) | 0% | 218.8 | 786,245 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 220.52 per share. | 04 Dec 2025 | 2,627 | 1,424,372 (8%) | 0% | 220.5 | 579,301 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 220.34 per share. | 04 Dec 2025 | 2,625 | 1,494,261 (8%) | 0% | 220.3 | 578,395 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 218.72 per share. | 04 Dec 2025 | 2,577 | 1,502,579 (8%) | 0% | 218.7 | 563,638 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 217.04 per share. | 04 Dec 2025 | 1,600 | 1,505,156 (8%) | 0% | 217.0 | 347,272 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 216.97 per share. | 04 Dec 2025 | 1,400 | 1,436,011 (8%) | 0% | 217.0 | 303,754 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 214.28 per share. | 04 Dec 2025 | 956 | 1,507,100 (8%) | 0% | 214.3 | 204,851 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 214.25 per share. | 04 Dec 2025 | 700 | 1,438,011 (8%) | 0% | 214.3 | 149,975 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 222.20 per share. | 04 Dec 2025 | 700 | 1,483,056 (8%) | 0% | 222.2 | 155,539 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 215.49 per share. | 04 Dec 2025 | 600 | 1,437,411 (8%) | 0% | 215.5 | 129,296 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 215.48 per share. | 04 Dec 2025 | 344 | 1,506,756 (8%) | 0% | 215.5 | 74,126 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 222.38 per share. | 04 Dec 2025 | 200 | 1,413,711 (8%) | 0% | 222.4 | 44,475 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.30 per share. | 14 Jul 2025 | 13,400 | 1,512,529 (8%) | 0% | 150.3 | 2,014,015 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.29 per share. | 14 Jul 2025 | 13,335 | 1,443,376 (8%) | 0% | 150.3 | 2,004,125 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.68 per share. | 14 Jul 2025 | 2,236 | 1,441,040 (8%) | 0% | 150.7 | 336,929 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.68 per share. | 14 Jul 2025 | 2,184 | 1,510,345 (8%) | 0% | 150.7 | 329,089 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 14 Jul 2025 | 1,529 | 1,438,711 (8%) | 0% | 150 | 229,350 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 14 Jul 2025 | 1,389 | 1,508,056 (8%) | 0% | 150 | 208,350 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 151.79 per share. | 14 Jul 2025 | 900 | 1,509,445 (8%) | 0% | 151.8 | 136,611 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 151.79 per share. | 14 Jul 2025 | 800 | 1,440,240 (8%) | 0% | 151.8 | 121,432 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 151.00 per share. | 14 Jul 2025 | 100 | 1,443,276 (8%) | 0% | 151 | 15,100 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.22 per share. | 09 Jul 2025 | 6,627 | 1,526,229 (8%) | 0% | 150.2 | 995,497 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.23 per share. | 09 Jul 2025 | 6,500 | 1,457,011 (8%) | 0% | 150.2 | 976,464 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 151.39 per share. | 09 Jul 2025 | 300 | 1,525,929 (8%) | 0% | 151.4 | 45,416 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 151.39 per share. | 09 Jul 2025 | 300 | 1,456,711 (8%) | 0% | 151.4 | 45,416 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.07 per share. | 09 Jul 2025 | 200 | 1,532,856 (8%) | 0% | 150.1 | 30,014 | Common Stock |
| Krystal Biotech Inc | Ms. Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.14 per share. | 09 Jul 2025 | 200 | 1,463,511 (8%) | 0% | 150.1 | 30,028 | Common Stock |